| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...858808L |
| P356 | DOI | 10.1371/JOURNAL.PONE.0058808 |
| P932 | PMC publication ID | 3597563 |
| P698 | PubMed publication ID | 23516559 |
| P5875 | ResearchGate publication ID | 235959671 |
| P2093 | author name string | Bo Li | |
| K-H William Lau | |||
| Michael H Walter | |||
| David J Baylink | |||
| Weirong Xing | |||
| Xuezhong Qin | |||
| Chandra Deb | |||
| Claudia Zannetti | |||
| Fatima Rajaallah | |||
| P2860 | cites work | Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 | Q24310398 |
| Epidemiologic evidence for multiple sclerosis as an infection | Q24615844 | ||
| TLR8 deficiency leads to autoimmunity in mice | Q28292240 | ||
| 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis | Q28475567 | ||
| Comparative analysis of species-specific ligand recognition in Toll-like receptor 8 signaling: a hypothesis | Q28477157 | ||
| Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis | Q28591514 | ||
| Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. | Q33920505 | ||
| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis | Q34312767 | ||
| Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. | Q50695778 | ||
| 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. | Q52607615 | ||
| Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement | Q84000892 | ||
| Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis | Q34344447 | ||
| Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential | Q34510368 | ||
| Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism. | Q35054693 | ||
| 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. | Q35192119 | ||
| Toll-like receptors in cerebral ischemic inflammatory injury | Q35416110 | ||
| A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis | Q35489860 | ||
| Toll-like receptor (TLR) and inflammasome actions in the central nervous system | Q36058919 | ||
| Toll-like receptors, endogenous ligands, and systemic autoimmune disease. | Q36079856 | ||
| Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis | Q36119099 | ||
| Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin | Q37146841 | ||
| Toll-like receptor signaling in endogenous neuroprotection and stroke | Q37171364 | ||
| Disease-modifying agents in the treatment of multiple sclerosis: a review of long-term outcomes. | Q37610482 | ||
| Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies | Q37771933 | ||
| Toll-like receptors expression and signaling in glia cells in neuro-amyloidogenic diseases: towards future therapeutic application | Q37779740 | ||
| Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis | Q37971896 | ||
| C/EBP{delta} and STAT-1 are required for TLR8 transcriptional activity. | Q38340976 | ||
| Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists | Q39980549 | ||
| Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides | Q40212635 | ||
| Vitamin D3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-induced IL-6 production in human monocytes | Q43077082 | ||
| Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis | Q44892486 | ||
| Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease | Q46645654 | ||
| Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. | Q46886748 | ||
| Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis | Q48249155 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| experimental autoimmune encephalomyelitis | Q494066 | ||
| P304 | page(s) | e58808 | |
| P577 | publication date | 2013-03-14 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo | |
| P478 | volume | 8 |
| Q35939705 | 1,25-Dihydroxyvitamin D3 attenuates endotoxin-induced production of inflammatory mediators by inhibiting MAPK activation in primary cortical neuron-glia cultures. |
| Q38542689 | A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention. |
| Q64987406 | Analysis of Association between Vitamin D Deficiency and Insulin Resistance. |
| Q51735384 | Deficient Arginase II Expression without Alteration in Arginase I Expression Attenuated Experimental Autoimmune Encephalomyelitis in Mice. |
| Q41260262 | Effect of Absent Immune Cell Expression of Vitamin D Receptor on Cardiac Allograft Survival in Mice. |
| Q38202921 | Genomic binding sites and biological effects of the vitamin D--VDR complex in multiple sclerosis [corrected]. |
| Q93050874 | Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis |
| Q38942965 | Ironing out the cross talk between FGF23 and inflammation |
| Q39847582 | MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice. |
| Q37375129 | Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 β -induced RANKL, OPG, TNF α , and IL-6 expression in human rheumatoid synoviocyte MH7A. |
| Q36087496 | Obesity-Related Oxidative Stress: the Impact of Physical Activity and Diet Manipulation |
| Q92290827 | Phase Angle: A Possible Biomarker to Quantify Inflammation in Subjects with Obesity and 25(OH)D Deficiency |
| Q47856590 | Protective Effect of 1,25-Dihydroxy Vitamin D3 on Pepsin-Trypsin-Resistant Gliadin-Induced Tight Junction Injuries |
| Q48854619 | Role of vitamin D in the physiopathology of neurodegenerative diseases |
| Q40416300 | The effect of 1, 25(OH)2 D3 (calcitriol) alone and in combination with all-trans retinoic acid on ROR-γt, IL-17, TGF-β, and FOXP3 gene expression in experimental autoimmune encephalomyelitis. |
| Q38236315 | The plasticity of inflammatory monocyte responses to the inflamed central nervous system. |
| Q38168570 | Toll-like receptors signaling in glomerular diseases |
| Q35597747 | Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis |
| Q44219240 | VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. |
| Q33833563 | Vitamin D in inflammatory diseases |
| Q39242378 | Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. |
Search more.